A multi-center open-label trial evaluating the efficacy and safety of daratumumab in treatment of patients with proliferative glomerulonephritis with monoclonal immunoglobulin deposits.
Thank you for your interest, but this study is recruiting by invitation only.
North Carolina (Statewide)
Patrick Taus
Medicine-Nephrology
Clinical or Medical
Interventional
Kidneys and Liver
24-1139
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
